Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Fast and Easy Test Could Revolutionize Blood Transfusions

By LabMedica International staff writers
Posted on 27 Jan 2026

Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. More...

Although blood units have a fixed expiration date, cells from different donors age at different rates, which can affect how well transfusions work, especially in vulnerable patients. Researchers have now developed a fast, chip-based test that can rapidly evaluate red blood cell quality after storage, offering a potential new tool to better manage blood supplies.

The test, developed through a collaboration between the University of Colorado Boulder (Boulder, CO, USA) and the University of Colorado Anschutz (Aurora, CO), fits on a single microchip and is designed to deliver results in about two minutes. The device, called a surface acoustic wave hemolysis assay, uses vibrations generated on a lithium niobate wafer to mechanically stress red blood cells. As the cells heat up and rupture, the system captures information that reflects membrane strength and overall cell health.

In laboratory tests using donor red blood cells, the researchers observed that some samples hemolyzed at lower temperatures than others. These samples also showed distinct metabolite patterns previously linked to aging red blood cells. The findings, published in Lab on a Chip, suggest that older or more fragile cells break down faster under acoustic stress, making the method a potential indicator of blood quality after storage.

If validated further, the chip-based test could help blood centers allocate higher-quality units to patients who need them most, such as children or individuals with conditions like sickle cell disease who require frequent transfusions. It may also reduce waste by improving decision-making around stored blood. In addition to transfusion medicine, the researchers believe similar lab-on-a-chip systems could be adapted to screen for blood-related diseases or monitor protein and metabolite changes linked to various health conditions.

“Our vision is to have a chip the size of a dime that you can plug into your cell phone,” said Associate Professor Xiaoyun Ding, senior author of the study. “It could use your phone’s camera and an app to read out the results in just two minutes.”

Related Links:
University of Colorado Boulder
University of Colorado Anschutz


Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Laboratory Software
ArtelWare
Hemodynamic System Monitor
OptoMonitor
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The TmS computational biomarker analyzes tumor gene expression and microenvironment data to guide treatment decisions (Photo courtesy of MD Anderson Cancer Center)

New Biomarker Predicts Chemotherapy Response in Triple-Negative Breast Cancer

Triple-negative breast cancer is an aggressive form of breast cancer in which patients often show widely varying responses to chemotherapy. Predicting who will benefit from treatment remains challenging,... Read more

Industry

view channel
Image: The initiative aims to speed next-generation diagnostic development during early pathogen emergence (photo courtesy of 123RF)

Cepheid Joins CDC Initiative to Strengthen U.S. Pandemic Testing Preparednesss

Cepheid (Sunnyvale, CA, USA) has been selected by the U.S. Centers for Disease Control and Prevention (CDC) as one of four national collaborators in a federal initiative to speed rapid diagnostic technologies... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.